TABLE 2.
Years | Lutathera revenue ($ million) | ASP per dose ($) | Implied number of Lutathera doses | Implied number of treatments (4 doses per treatment) |
2018 | 167 | 20,000 | 8,350 | 2,088 |
2019 | 441 | 20,000 | 22,050 | 5,513 |
2020 | 445 | 20,000 | 22,250 | 5,563 |
2021 | 475 | 20,000 | 23,750 | 5,938 |
Source: (93), Novartis annual report 2021.